Nudge
CompanyAnnouncing our $100M Series A Led by Thrive Capital and Greenoaks
About half of all people will experience a neurological or psychiatric disorder in their lifetime.1 While we’ve made significant advances in treating infectious diseases, cancer, and cardiovascular conditions, progress in brain health has lagged far behind. These disorders, like addiction, chr
Date
Jul 22, 2025
Category
biotech
Lead investor
Thrive Capital
Stage
Series A
Size
$100M
Wing VC
Avenir
Sapphire Ventures
EQT Ventures
General Catalyst
Bain Capital Ventures
Felicis
Kleiner Perkins
VMG Partners